Cargando…

Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia

Detalles Bibliográficos
Autores principales: Borg, Michelle A., Clemmons, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167086/
https://www.ncbi.nlm.nih.gov/pubmed/30310726
_version_ 1783360142606073856
author Borg, Michelle A.
Clemmons, Amber
author_facet Borg, Michelle A.
Clemmons, Amber
author_sort Borg, Michelle A.
collection PubMed
description
format Online
Article
Text
id pubmed-6167086
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-61670862018-10-11 Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia Borg, Michelle A. Clemmons, Amber J Adv Pract Oncol Review Article Harborside Press 2017 2017-09-01 /pmc/articles/PMC6167086/ /pubmed/30310726 Text en Copyright © 2017, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Borg, Michelle A.
Clemmons, Amber
Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia
title Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia
title_full Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia
title_fullStr Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia
title_full_unstemmed Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia
title_short Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia
title_sort venetoclax: a novel treatment for patients with del(17p) chronic lymphocytic leukemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167086/
https://www.ncbi.nlm.nih.gov/pubmed/30310726
work_keys_str_mv AT borgmichellea venetoclaxanoveltreatmentforpatientswithdel17pchroniclymphocyticleukemia
AT clemmonsamber venetoclaxanoveltreatmentforpatientswithdel17pchroniclymphocyticleukemia